|
Dr. Zuber joined Lentigen in January 2006. Dr. Zuber has 25 years of experience beyond his Ph.D. (Madras University in India) that includes 10 years of biotechnology industry experience in adenoviral and lentiviral vector systems. Prior to joining Lentigen, Dr. Zuber spent 8 years in Research & Development at GenVec, where he was very successful in developing novel technologies for adenoviral vector and library construction, adenovirus based vaccines and the generation of clinical candidate adenovirus-based vaccines. Dr. Zuber has 15 years of academic research experience in molecular microbiology with a particular emphasis on bacterial and phage genetics. Dr. Zuber has authored several research publications in peer-reviewed scientific journals. | 